In the quarter, growth in cancer drugs moderated generic competition and pricing pressures in respiratory and diabetes markets. We expect this trend to continue, but the gains in cancer drugs should ...

One of the biggest challenges of evaluating and planning the energy economy is the existence of what economists call externalities, or externalized costs. Any activity that causes damage to the ...

Prellis Biologics, Inc. today announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus. Using the ...

Nutrition and public policy expert Marion Nestle answers readers' questions in this monthly column written exclusively for The Chronicle. E-mail your questions to [email protected], with "Marion ...